Association of topical glaucoma medications with lacrimal drainage obstruction and eyelid malposition

Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–7. https://doi.org/10.1136/bjo.2005.081224.

Article  Google Scholar 

Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: A review. JAMA J Am Med Assoc. 2014;311:1901–11.

Article  Google Scholar 

Prum BE, Rosenberg LF, Gedde SJ, Mansberger SL, Stein JD, Moroi SE, et al. Primary Open-Angle Glaucoma Preferred Practice Pattern® Guidelines. Ophthalmology. 2016;123:P41–111.

Article  Google Scholar 

Quinn MP, Johnson D, Whitehead M, Gill SS, Campbell RJ. Predictors of Initial Glaucoma Therapy with Laser Trabeculoplasty versus Medication. Ophthalmol Glaucoma. 2021;4:358–64. https://linkinghub.elsevier.com/retrieve/pii/S258941962030301X.

Servat JJ, Bernardino CR. Effects of Common Topical Antiglaucoma Medications on the Ocular Surface, Eyelids and Periorbital Tissue. Drugs Aging. 2011;28:267–82. https://doi.org/10.2165/11588830-000000000-00000.

Article  Google Scholar 

Gazzard G, Konstantakopoulou E, Garway-Heath D, Garg A, Bunce C, Wormald R, et al. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet. 2019;393:1505–16.

Article  Google Scholar 

Saheb H, Ahmed IIK. Micro-invasive glaucoma surgery. Curr Opin Ophthalmol. 2012;23:96–104. https://journals.lww.com/00055735-201203000-00004.

Beckers HJM, Schouten JSAG, Webers CAB, van der Valk R, Hendrikse F. Side effects of commonly used glaucoma medications: comparison of tolerability, chance of discontinuation, and patient satisfaction. Graefes Arch Clin Exp Ophthalmol. 2008;246:1485–90. https://doi.org/10.1007/s00417-008-0875-7.

Article  Google Scholar 

McNab AA. Lacrimal canalicular obstruction associated with topical ocular medication. Aust N Z J Ophthalmol. 1998;26:219–23.

Article  Google Scholar 

Seider N, Miller B, Beiran I. Topical Glaucoma Therapy as a Risk Factor for Nasolacrimal Duct Obstruction. Am J Ophthalmol. 2008;145:120–3. https://linkinghub.elsevier.com/retrieve/pii/S0002939407006897.

Kashkouli MB, Rezaee R, Nilforoushan N, Salimi S, Foroutan A, Naseripour M. Topical Antiglaucoma Medications and Lacrimal Drainage System Obstruction. Ophthalmic Plast Reconstr Surg. 2008;24:172–5. https://journals.lww.com/00002341-200805000-00002.

Britt MT, Burnstine MA. Iopidine allergy causing lower eyelid ectropion progressing to cicatricial entropion. Br J Ophthalmol. 1999;83:992–3.

Article  Google Scholar 

Bearden W, Anderson R. Trichiasis Associated With Prostaglandin Analog Use. Ophthalmic Plast Reconstr Surg. 2004;20:320–2. https://journals.lww.com/00002341-200407000-00015.

D’Ostroph AO, Dailey RA. Cicatricial Entropion Associated With Chronic Dipivefrin Application. Ophthal Plast Reconstr Surg. 2001;17:328–31. http://journals.lww.com/00002341-200109000-00006.

Golan S, Rabina G, Kurtz S, Leibovitch I. The prevalence of glaucoma in patients undergoing surgery for eyelid entropion or ectropion. Clin Interv Aging. 2016;11:1429–32. https://doi.org/10.2147/CIA.S97694. Accessed 24 May 2020.

Article  Google Scholar 

Aristodemou P, Baer R. Reversible Cicatricial Ectropion Precipitated by Topical Brimonidine Eye Drops. Ophthalmic Plast Reconstr Surg. 2008;24:57–8. http://journals.lww.com/00002341-200801000-00018.

Hegde V, Robinson R, Dean F, Mulvihill HA, Ahluwalia H. Drug-Induced Ectropion. Ophthalmology. 2007;114:362–6. https://linkinghub.elsevier.com/retrieve/pii/S0161642006014503. Accessed 24 May 2020.

Bartley GB. Reversible lower eyelid ectropion associated with dipivefrin. Am J Ophthalmol. 1991;111:650–1.

Article  Google Scholar 

Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Philip Miller J, et al. The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701–13.

Article  Google Scholar 

Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268–79.

Gaasterland DE, Ederer F, Beck A, Costarides A, Leef D, Closek J, et al. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:429–40.

Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943–53.

Article  Google Scholar 

Anderson DR, Drance SM, Schulzer M. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126:487–97.

Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement. PLOS Med. 2015;12:e1001885. https://doi.org/10.1371/journal.pmed.1001885.

Article  Google Scholar 

Campbell RJ, Bell CM, Paterson JM, Bronskill SE, Moineddin R, Whitehead M, et al. Stroke rates after introduction of vascular endothelial growth factor inhibitors for macular degeneration: A time series analysis. Ophthalmology. 2012;119:1604–8.

Article  Google Scholar 

Campbell RJ, Gill SS, Bronskill SE, Paterson JM, Whitehead M, Bell CM. Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study. BMJ. 2012;345:e4203.

Article  Google Scholar 

Quinn MP, Johnson D, Whitehead M, Gill SS, Campbell RJ. Distribution and Predictors of Initial Glaucoma Care Among Ophthalmologists and Optometrists: A Population-based Study. J Glaucoma. 2021;30:e300–4. https://doi.org/10.1097/IJG.0000000000001792.

Article  Google Scholar 

Williams JI, Young W. A summary of studies on the quality of health care administration databases in Canada. In: Goel V, Williams JI, Anderson GM, Blackstien-Hirsh P, Fooks C, Naylor D, editors. Patterns of Health Care in Ontario: The ICES Practice Atlas. 2nd ed. Ottawa: Canadian Medical Association; 1996. pp. 339–45. https://www.ices.on.ca/~/media/Files/Atlases-Reports/1996/Patterns-of-health-care-in-Ontario-2nd-edition/Full-report.ashx.

Levy AR, O’Brien BJ, Sellors C, Grootendorst P, Willison D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol. 2003;10:67–71.

Google Scholar 

Juurlink D, Preyra C, Croxford R, Chong A, Austin P, Tu J, et al. Canadian institute for health information discharge abstract database: a validation study. 2006. https://www.ices.on.ca/Publications/Atlases-and-Reports/2006/Canadian-Institute-for-Health-Information. Accessed 29 April 2020.

Gruneir A, Bell CM, Bronskill SE, Schull M, Anderson GM, Rochon PA. Frequency and pattern of emergency department visits by long-term care residents - A population-based study. J Am Geriatr Soc. 2010;58:510–7.

Article  Google Scholar 

Gill SS, Anderson GM, Fischer HD, Bell CM, Li P, Normand SLT, et al. Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: A population-based cohort study. Arch Intern Med. 2009;169:867–73.

Article  Google Scholar 

Campbell RJ, Bell CM, Gill SS, Trope GE, Buys YM, Whitehead M, et al. Subspecialization in glaucoma surgery. Ophthalmology. 2012;119:2270–3.

Article  Google Scholar 

Zhou Z, Rahme E, Abrahamowicz M, Pilote L. Survival Bias Associated with Time-to-Treatment Initiation in Drug Effectiveness Evaluation: A Comparison of Methods. Am J Epidemiol. 2005;162:1016–23. http://academic.oup.com/aje/article/162/10/1016/65057/Survival-Bias-Associated-with-TimetoTreatment.

Normand SLT, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, Cleary PD, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: A matched analysis using propensity scores. J Clin Epidemiol. 2001;54:387–98.

Article  Google Scholar 

Austin PC, Mamdani MM. A comparison of propensity score methods: A case-study estimating the effectiveness of post-AMI statin use. Stat Med. 2006;25:2084–106.

Article  Google Scholar 

Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34:3661–79.

Article  Google Scholar 

Xie J, Liu C. Adjusted Kaplan–Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Stat Med. 2005;24:3089–31. https://doi.org/10.1002/sim.2174.

Article  Google Scholar 

Austin PC. The performance of different propensity score methods for estimating marginal hazard ratios. Stat Med. 2013;32:2837–49. https://onlinelibrary.wiley.com/doi/10.1002/sim.5705.

Allison PD. Survival analysis using SAS: a practical guide, second edition, 2nd ed. Cary, N.C: SAS Pub; 2010.

Altman DG, Andersen PK. Calculating the number needed to treat for trials where the outcome is time to an event. BMJ 1999;319:1492–5. https://doi.org/10.1136/bmj.319.7223.1492.

Article  Google Scholar 

Altman DG. Confidence intervals for the number needed to treat. BMJ. 1998;317:1309–12. https://doi.org/10.1136/bmj.317.7168.1309.

Article  Google Scholar 

Ohtomo K, Ueta T, Toyama T, Nagahara M. Predisposing factors for primary acquired nasolacrimal duct obstruction. Graefe’s Arch. Clin Exp Ophthalmol 2013;251:1835–9. https://doi.org/10.1007/s00417-013-2288-5.

Article  Google Scholar 

Pisella PJ, Pouliquen P, Baudouin C, Grasso CM. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Evid Based Eye Care. 2002;3:140–1.

Article  Google Scholar 

Dart JK. The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on. Eye. 2017;31:301–32. http://www.nature.com/articles/eye2016284.

Broadway D, Grierson I, Hitchings R. Adverse effects of topical antiglaucomatous medications on the conjunctiva. Br J Ophthalmol. 1993;77:590–6. https://doi.org/10.1136/bjo.77.9.590.

Article  Google Scholar 

Thorne JE, Anhalt GJ, Jabs DA. Mucous Membrane Pemphigoid and Pseudopemphigoid. Ophthalmology. 2004;111:45–52.

Shah M, Lee G, Lefebvre DR, Kronberg B, Loomis S, Brauner SC, et al. A Cross-Sectional Survey of the Association between Bilateral Topical Prostaglandin Analogue Use and Ocular Adnexal Features Boulton ME (ed). PLoS ONE. 2013;8:e61638. https://doi.org/10.1371/journal.pone.0061638.

Article  Google Scholar 

Sipkova Z, Vonica O, Olurin O, Obi EE, Pearson AR. Assessment of patientreported outcome and quality of life improvement following surgery for epiphora. Eye. 2017;31:1664–71. https://doi.org/10.1038/eye.2017.120.

Article  Google Scholar 

Steven DW, Alaghband P, Lim KS. Preservatives in glaucoma medication. Br J Ophthalmol. 2018;102:1497–503. https://doi.org/10.1136/bjophthalmol-2017-311544.

Article  Google Scholar 

留言 (0)

沒有登入
gif